Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Item No. 19354

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
2-Guanidinoethylmercaptosuccinic acid (GEMSA) is a potent inhibitor of enkephalin convertase (Ki = 8.8 nM) that is functional in vivo.1,2 It is a peptidomimetic inhibitor, occupying the specificity pocket of the enzyme.3 GEMSA can also inhibit other carboxypeptidases, including thrombin-activatable fibrinolysis inhibitor.4,5
WARNING This product is not for human or veterinary use.
1. Analgesic and convulsant effects of guanidinoethylmercaptosuccinic acid (GEMSA)--
2. In vivo modulation of rat hypothalamic opioid peptide content by intracerebroventricular injection of guanidinoethylmercaptosuccinic acid (GEMSA): Possible physiological role of enkephalin convertase. Brain Res. 492(1-2), 305-313 (1989).
3. The crystal structure of the inhibitor-
4. Purification and characterization of TAFI, a thrombin-
5. The membrane-